GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
162 hedge funds and large institutions have $974M invested in GenMark Diagnostics, Inc in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 56 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
7% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 56
73% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $6.01M
Holders
162
Holding in Top 10
3
Calls
$1.63M
Puts
$6.01M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$11.3M | |
| 3 | +$11.2M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.95M |
| 5 |
Morgan Stanley
New York
|
+$9.29M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$11M | |
| 3 | -$10.8M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.2M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$4.54M |